The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 331:333-334 August 4, 1994 Number 5
NextNext

Racial Differences in the Use of Drug Therapy for HIV Disease

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Moore, R. D.
-PubMed Citation
To the Editor: Moore et al. (March 17 issue)1 present data suggesting that among patients seeking treatment at their Baltimore HIV clinic, blacks were less likely than whites to have received previous antiretroviral therapy or prophylaxis against Pneumocystis carinii pneumonia (PCP). Although data were obtained from patients' reports and "accompanying medical records when available," Moore and colleagues do not report the degree to which data from patients' reports were validated by reviews of medical records.

As part of an ongoing interview project sponsored by the Centers for Disease Control and Prevention,2 we have collected similar data on medical care in . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.